50-12-103. Availability of experimental drugs. (1) A manufacturer of an investigational drug, biological product, or device may make the drug, product, or device available to an eligible patient who has requested the drug, product, or device pursuant to this part.
     (2) The manufacturer may:
     (a) provide an investigational drug, biological product, or device to an eligible patient without receiving compensation; or
     (b) require an eligible patient to pay the costs of or the costs associated with the manufacture of the investigational drug, biological product, or device.
     (3) A manufacturer is not required to make an investigational drug, biological product, or device available to an eligible patient.

     History: En. Sec. 3, Ch. 135, L. 2015.